Oseltamivir, amantadine, and ribavirin combination antiviral therapy versus oseltamivir monotherapy for the treatment of influenza: a multicentre, double-blind, randomised phase 2 trial

Overview of attention for article published in Lancet Infectious Diseases, September 2017

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (86th percentile)

Mentioned by

news: 6 news outlets
policy: 1 policy source
twitter: 64 X users
patent: 1 patent

facebook: 3 Facebook pages
googleplus: 1 Google+ user
guideline: 1 clinical guideline source

Readers on

mendeley: 190 Mendeley

So far, Altmetric has seen 70 X posts from 64 X users, with an upper bound of 553,619 followers.

@epuro2014 @MarcelaSaebL https://t.co/rBawSvDgg3

@MarcelaSaebL https://t.co/rBawSvDgg3

RT @drbrainbugz: Use of combination antiviral therapy against influenza virus leads to reduced viral shedding but no clinical significant d…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 66 additional X posts.